Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta-analysis - PubMed (original) (raw)
Meta-Analysis
. 2018 Apr;20(4):1040-1043.
doi: 10.1111/dom.13160. Epub 2017 Dec 12.
Affiliations
- PMID: 29135080
- DOI: 10.1111/dom.13160
Meta-Analysis
Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta-analysis
Andrew McGovern et al. Diabetes Obes Metab. 2018 Apr.
Abstract
Limited medication adherence and persistence with treatment are barriers to successful management of type 2 diabetes (T2D). We searched MEDLINE, EMBASE, the Cochrane Library, the Register of Controlled Trials, PsychINFO and CINAHL for observational and interventional studies that compared the adherence or persistence associated with 2 or more glucose-lowering medications in people with T2D. Where 5 or more studies provided the same comparison, a random-effects meta-analysis was performed, reporting mean difference (MD) or odds ratio (OR) for adherence or persistence, depending on the pooled study outcomes. We included a total of 48 studies. Compared with metformin, adherence (%) was better for sulphonylureas (5 studies; MD 10.6%, 95% confidence interval [CI] 6.5-14.7) and thiazolidinediones (TZDs; 6 studies; MD 11.3%, 95% CI 2.7%-20.0%). Adherence to TZDs was marginally better than adherence to sulphonylureas (5 studies; MD 1.5%, 95% CI 0.1-2.9). Dipeptidyl peptidase-4 inhibitors had better adherence than sulphonylureas and TZDs. Glucagon-like peptide-1 receptor agonists had higher rates of discontinuation than long-acting analogue insulins (6 studies; OR 1.95; 95% CI 1.17-3.27). Long-acting insulin analogues had better persistence than human insulins (5 studies; MD 43.1 days; 95% CI 22.0-64.2). The methods used to define adherence and persistence were highly variable.
Keywords: GLP-1 analogue; antidiabetic drug; insulin analogues; medication adherence; medication persistence; meta-analysis; systematic review; type 2 diabetes.
© 2017 John Wiley & Sons Ltd.
Similar articles
- Real-world adherence, persistence, and in-class switching during use of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis involving 594,138 patients with type 2 diabetes.
Ogundipe O, Mazidi M, Chin KL, Gor D, McGovern A, Sahle BW, Jermendy G, Korhonen MJ, Appiah B, Ademi Z, De Bruin ML, Liew D, Ofori-Asenso R. Ogundipe O, et al. Acta Diabetol. 2021 Jan;58(1):39-46. doi: 10.1007/s00592-020-01590-w. Epub 2020 Aug 18. Acta Diabetol. 2021. PMID: 32809070 - Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol.
McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S. McGovern A, et al. BMJ Open. 2016 Feb 29;6(2):e010469. doi: 10.1136/bmjopen-2015-010469. BMJ Open. 2016. PMID: 26928029 Free PMC article. - Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
Iglay K, Cartier SE, Rosen VM, Zarotsky V, Rajpathak SN, Radican L, Tunceli K. Iglay K, et al. Curr Med Res Opin. 2015;31(7):1283-96. doi: 10.1185/03007995.2015.1053048. Epub 2015 Jun 18. Curr Med Res Opin. 2015. PMID: 26023805 - Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T. Hemmingsen B, et al. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009008. doi: 10.1002/14651858.CD009008.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633364 Updated. Review. - Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus.
Farr AM, Sheehan JJ, Curkendall SM, Smith DM, Johnston SS, Kalsekar I. Farr AM, et al. Adv Ther. 2014 Dec;31(12):1287-305. doi: 10.1007/s12325-014-0171-3. Epub 2014 Dec 12. Adv Ther. 2014. PMID: 25504156 Free PMC article.
Cited by
- Medication Engagement, Determinants of Health, and A1C Levels Among Adults With Type 2 Diabetes within a Tribal Health System.
Nelson T, Wilkie DJ, Yao Y, Segal R, DeVaughan-Circles A, Donahoo WT, Goins RT, Manson SM, Legaspi AB, Scarton L. Nelson T, et al. Sci Diabetes Self Manag Care. 2024 Aug;50(4):275-286. doi: 10.1177/26350106241259007. Epub 2024 Jul 31. Sci Diabetes Self Manag Care. 2024. PMID: 39082085 Free PMC article. - Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?
Borner T, Tinsley IC, Doyle RP, Hayes MR, De Jonghe BC. Borner T, et al. Br J Pharmacol. 2022 Feb;179(4):542-556. doi: 10.1111/bph.15647. Epub 2021 Sep 14. Br J Pharmacol. 2022. PMID: 34363224 Free PMC article. Review. - Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative Review.
Boye KS, Shinde S, Kennedy-Martin T, Robinson S, Thieu VT. Boye KS, et al. Patient Prefer Adherence. 2022 Jan 6;16:23-39. doi: 10.2147/PPA.S328583. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 35023906 Free PMC article. Review. - Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial.
Mita T, Hiyoshi T, Yoshii H, Chimori H, Ikeda K, Sato J, Watada H. Mita T, et al. Diabetes Ther. 2018 Jun;9(3):1403-1412. doi: 10.1007/s13300-018-0437-x. Epub 2018 May 9. Diabetes Ther. 2018. PMID: 29744822 Free PMC article. - Assessment of inter-rater agreement between physicians and their patients regarding medication adherence in a clinical questionnaire study.
Otsu Y, Kai M, Suematsu Y, Kiyomi F, Saku K, Kamimura H, Miura SI. Otsu Y, et al. Medicine (Baltimore). 2019 May;98(18):e15188. doi: 10.1097/MD.0000000000015188. Medicine (Baltimore). 2019. PMID: 31045761 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical